Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davinder Gill

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Mabs|May 17, 2013
Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domainMischa R Müller, Kenneth Saunders, Christopher Grace, et al.
Mabs|April 29, 2010
In vitro potency, pharmacokinetic profiles, and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupusYulia Vugmeyster, Heath Guay, Pamela Szklut, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 14, 2008
Interleukin-13 neutralization by two distinct receptor blocking mechanisms reduces immunoglobulin E responses and lung inflammation in cynomolgus monkeysMarion T Kasaian, Xiang-Yang Tan, Macy Jin, et al.
Human Vaccines & Immunotherapeutics|September 19, 2019
A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infantsVibhu Kanchan, Khalequ Zaman, Asma Binte Aziz, et al.
Rheumatology (Oxford, England)|January 25, 2011
Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeysCheryl Nickerson-Nutter, Lioudmila Tchistiakova, Nilufer P Seth, et al.
Journal of Molecular Biology|February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potentialCiara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Vaccine|July 5, 2021
A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in BangladeshFahima Chowdhury, Khalid Ali Syed, Afroza Akter, et al.
Journal of Molecular Biology|March 17, 2009
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regionsWilliam J Finlay, Orla Cunningham, Matthew A Lambert, et al.
The Journal of Biological Chemistry|November 20, 2009
Structural correlates of antibodies associated with acute reversal of amyloid beta-related behavioral deficits in a mouse model of Alzheimer diseaseGuriqbal S Basi, Hadar Feinberg, Farshid Oshidari, et al.
The Journal of Biological Chemistry|November 14, 2012
An ultra-specific avian antibody to phosphorylated tau protein reveals a unique mechanism for phosphoepitope recognitionHeather H Shih, Chao Tu, Wei Cao, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Mabs|May 17, 2013
Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domainMischa R Müller, Kenneth Saunders, Christopher Grace, et al.
Mabs|April 29, 2010
In vitro potency, pharmacokinetic profiles, and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupusYulia Vugmeyster, Heath Guay, Pamela Szklut, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 14, 2008
Interleukin-13 neutralization by two distinct receptor blocking mechanisms reduces immunoglobulin E responses and lung inflammation in cynomolgus monkeysMarion T Kasaian, Xiang-Yang Tan, Macy Jin, et al.
Human Vaccines & Immunotherapeutics|September 19, 2019
A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infantsVibhu Kanchan, Khalequ Zaman, Asma Binte Aziz, et al.
Rheumatology (Oxford, England)|January 25, 2011
Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeysCheryl Nickerson-Nutter, Lioudmila Tchistiakova, Nilufer P Seth, et al.
Journal of Molecular Biology|February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potentialCiara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Vaccine|July 5, 2021
A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in BangladeshFahima Chowdhury, Khalid Ali Syed, Afroza Akter, et al.
Journal of Molecular Biology|March 17, 2009
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regionsWilliam J Finlay, Orla Cunningham, Matthew A Lambert, et al.
The Journal of Biological Chemistry|November 20, 2009
Structural correlates of antibodies associated with acute reversal of amyloid beta-related behavioral deficits in a mouse model of Alzheimer diseaseGuriqbal S Basi, Hadar Feinberg, Farshid Oshidari, et al.
The Journal of Biological Chemistry|November 14, 2012
An ultra-specific avian antibody to phosphorylated tau protein reveals a unique mechanism for phosphoepitope recognitionHeather H Shih, Chao Tu, Wei Cao, et al.
Pageof 3